Plewman Patrick reported option exercise involving 4,274 derivative units of QUEST DIAGNOSTICS INC at $127.73 for −$546k on Nov 9, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SVP for Diagnostic Services
SVP for Diagnostic Services
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
−$545,896.65Shares × reported price
Shares traded
4,274Non-Qualifed Stock Option (right to buy)
Price per share
$127.73Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 9, 2026Option exercise
Filed
Nov 12, 2026, 7:13 PM ET4-day reporting delay
Accession
0001022079-26-000125Code M · Transaction 399946
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Option exercise4,274$127.73$545,896.65Trade 399941
Nov 9, 2026Option exercise6,793$127.81$868,179.37Trade 399943
Nov 9, 2026Sell4,274$257.34−$1,099,871.16Trade 399942
Nov 9, 2026Sell6,793$257.34−$1,748,110.62Trade 399944
Nov 9, 2026Sell650$257.34−$167,271Trade 399945
Nov 9, 2026Option exercise6,793$127.81−$868,179.37Trade 399947
7 transaction rows in this filing. Joint filers share the same rows.

DGX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
DGX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −11%1w ago −3.4%1d ago −1.5%
Returns since7d30d90d180d1y

Footnotes in full

F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.